Concord Drugs

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue6.3511.8510.777.9613.38
Expenses6.3311.7810.267.9413.23
EBITDA0.740.801.320.930.94
EBIT0.400.460.950.550.57
Profit Before Tax0.020.070.520.020.15
Net Profit0.010.050.220.010.11
Financial Ratios
Operating Profit Margin11.50%6.76%12.16%11.68%7.03%
Net Profit Margin0.16%0.42%2.04%0.13%0.82%
Earning Per Share (Diluted)0.010.050.220.010.11
Dividends Per Share0.000.000.000.000.00